nach oben

Journal of Thrombosis and Thrombolysis

Erschienen in:

05.02.2021

The allergic myocardial infarction dilemma: is it the anaphylaxis or the epinephrine?

verfasst von: Pei Zheng Tan, Nicholas W. S. Chew, Sen Hee Tay, Peter Chang

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

We highlight two distinct cases of myocardial infarction occurring concurrently with anaphylaxis at our centre in Singapore. The first case had cardiac symptoms and electrocardiogram changes concomitant with his anaphylaxis presentation, suggestive of Kounis syndrome, while the second case presented with anaphylaxis and only developed cardiac symptoms and electrocardiogram changes after treatment with intramuscular epinephrine, suggestive of epinephrine-induced myocardial infarction. Both these conditions are uncommon and under-recognised, and we review the current literature to compare the similarities and differences in their clinical manifestations, pathophysiology, and management. Kounis syndrome occurs secondary to mast cell degranulation ultimately resulting in coronary vasospasm, platelet activation and inflammatory response, whereas epinephrine causes platelet aggregation. Therefore, treatment priorities of Kounis syndrome are treatment of allergy, treatment of vasospasm, and treatment with anti-platelet therapy and revascularization if coronary plaques are present. For epinephrine-induced myocardial infarction, after epinephrine treatment is discontinued, considerations in management are re-vascularisation or pharmacotherapy. Further research will help with better understanding of both conditions and formulation of clinical management guidelines.

Shaker MS, Wallace DV, Golden DBK et al (2020) Anaphylaxis—a 2020 practice parameter update, systematic review, and grading of recommendations, assessment, development and evaluation (GRADE) analysis. J Allergy Clin Immunol 145(4):1082–1123. https://doi.org/10.1016/j.jaci.2020.01.017CrossRefPubMed

Simons FER, Ebisawa M, Sanchez-Borges M et al (2015) 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines. World Allergy Organ J 8:1–16. https://doi.org/10.1186/s40413-015-0080-1CrossRef

Muraro A, Werfel T, Hoffmann-Sommergruber K, Roberts G et al (2014) EAACI Food Allergy and Anaphylaxis Guidelines Group. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy 69(8):1008–1025. https://doi.org/10.1111/all.12429CrossRefPubMed

Matsuo H, Morimoto K, Akaki T et al (2005) Exercise and aspirin increase levels of circulating gliadin peptides in patients with wheat-dependent exercise-induced anaphylaxis. Clin Exp Allergy 35(4):461–466. https://doi.org/10.1111/j.1365-2222.2005.02213.xCrossRefPubMed

Kivity S, Sneh E, Greif J et al (1988) The effect of food and exercise on the skin response to compound 48/80 in patients with food-associated exercise-induced urticaria-angioedema. J Allergy Clin Immunol 81(6):1155–1158. https://doi.org/10.1016/0091-6749(88)90884-6CrossRefPubMed

Tam C-J, John RM (2017) Food-dependent exercise-induced anaphylaxis: a review. J Nurse Pract 13(5):313–321CrossRef

Feldweg AM (2017) Food-dependent, exercise-induced anaphylaxis: diagnosis and management in the outpatient setting. J Allergy Clin Immunol Pract 5(2):283–288. https://doi.org/10.1016/j.jaip.2016.11.022CrossRefPubMed

Li J, Zheng J, Zhou Y et al (2018) Acute coronary syndrome secondary to allergic coronary vasospasm (Kounis Syndrome): a case series, follow-up and literature review. BMC Cardiovasc Disord 18(1):42. https://doi.org/10.1186/s12872-018-0781-9CrossRefPubMedPubMedCentral

Kounis NG (2006) Kounis syndrome (allergic angina and allergic myocardial infarction): a natural paradigm? Int J Cardiol 110(1):7–14. https://doi.org/10.1016/j.ijcard.2005.08.007CrossRefPubMed

10.

Kounis NG (2016) Kounis syndrome: an update on epidemiology, pathogenesis, diagnosis and therapeutic management. Clin Chem Lab Med 54(10):1545–1559. https://doi.org/10.1515/cclm-2016-0010CrossRefPubMed

11.

Johnson JL, Jackson CL, Angelini GD et al (1998) Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 18(11):1707–1715. https://doi.org/10.1161/01.atv.18.11.1707CrossRefPubMed

12.

Toya T, Kagami K, Adachi T (2019) Friend or foe: food-dependent exercise-induced anaphylaxis associated with acute coronary syndrome aggravated by adrenaline and aspirin: a case report. Eur Heart J Case Rep 3(3):ytz143. https://doi.org/10.1093/ehjcr/ytz143CrossRefPubMedPubMedCentral

13.

Aihara M, Miyazawa M, Osuna H et al (2002) Food-dependent exercise-induced anaphylaxis: influence of concurrent aspirin administration on skin testing and provocation. Br J Dermatol 146(3):466–472. https://doi.org/10.1046/j.1365-2133.2002.04601.xCrossRefPubMed

14.

Helbling A, Hurni T, Mueller UR et al (2004) Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 34(2):285–290. https://doi.org/10.1111/j.1365-2222.2004.01882.xCrossRefPubMed

15.

Kounis NG, Soufras GD, Davlouros P et al (2015) Combined etiology of anaphylactic cardiogenic shock: amiodarone, epinephrine, cardioverter defibrillator, left ventricular assist devices and the Kounis syndrome. Ann Card Anaesth 18(2):261–264. https://doi.org/10.4103/0971-9784.154498CrossRefPubMedPubMedCentral

16.

Akoz A, Tanboga HI, Emet M et al (2013) A prospective study of Kounis syndrome: clinical experience and cardiac magnetic resonance imaging findings for 21 patients. Acta Med Mediterr 9:811–816

17.

Yanagawa Y, Kondo A, Ishikawa K et al. (2017) Kounis syndrome should be excluded when physicians treat patients with anaphylaxis. Ann Allergy Asthma Immunol 119(4):392. https://doi.org/10.1016/j.anai.2017.08.003

18.

Abdelghany M, Subedi R, Shah S et al (2017) Kounis syndrome: a review article on epidemiology, diagnostic findings, management and complications of allergic acute coronary syndrome. Int J Cardiol 232:1–4. https://doi.org/10.1016/j.ijcard.2017.01.124CrossRefPubMed

19.

Fassio F, Losappio L, Antolin-Amerigo D et al (2016) Kounis syndrome: a concise review with focus on management. Eur J Intern Med 30:7–10. https://doi.org/10.1016/j.ejim.2015.12.004CrossRefPubMed

20.

Ridella M, Bagdure S, Nugent K et al (2009) Kounis syndrome following beta-lactam antibiotic use: review of literature. Inflamm Allergy Drug Targets 8(1):11–16. https://doi.org/10.2174/187152809787582462CrossRefPubMed

21.

O’Gara PT, Kushner FG, Ascheim DD et al (2013) American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127(4):e362–e425. https://doi.org/10.1161/CIR.0b013e3182742cf6CrossRefPubMed

22.

Kounis NG (2013) Coronary hypersensitivity disorder: the Kounis syndrome. Clin Ther 35(5):563–571. https://doi.org/10.1016/j.clinthera.2013.02.022CrossRefPubMed

23.

Overgaard CB, Dzavík V (2008) Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease. Circulation 118(10):1047–1056. https://doi.org/10.1161/CIRCULATIONAHA.107.728840CrossRefPubMed

24.

Laustiola K, Kaukinen S, Seppälä E et al (1986) Adrenaline infusion evokes increased thromboxane B2 production by platelets in healthy men: the effect of beta-adrenoceptor blockade. Eur J Clin Invest 16(6):473–479. https://doi.org/10.1111/j.1365-2362.1986.tb02164.xCrossRefPubMed

25.

Wallén NH, Goodall AH, Li N et al (1999) Activation of haemostasis by exercise, mental stress and adrenaline: effects on platelet sensitivity to thrombin and thrombin generation. Clin Sci (Lond) 97(1):27–35CrossRef

26.

Jayamali WD, Herath HMMTB, Kulathunga A (2017) Myocardial infarction during anaphylaxis in a young healthy male with normal coronary arteries—is epinephrine the culprit? BMC Cardiovasc Disord 17(1):237. https://doi.org/10.1186/s12872-017-0670-7CrossRefPubMedPubMedCentral

27.

Jackson CE, Dalzell JR, Hogg KJ (2009) Epinephrine treatment of anaphylaxis: an extraordinary case of very late acute stent thrombosis. Circ Cardiovasc Interv 2(1):79–81. https://doi.org/10.1161/CIRCINTERVENTIONS.108.820266CrossRefPubMed

28.

Zakka K, Gadi S, Koshlelashvili N et al (2020) Acute myocardial injury after administration of intravenous epinephrine for allergic reaction. SAGE Open Med Case Rep. https://doi.org/10.1177/2050313X20933104CrossRefPubMedPubMedCentral

29.

Cunnington C, McDonald JE, Singh RK (2013) Epinephrine-induced myocardial infarction in severe anaphylaxis: is nonselective β-blockade a contributory factor? Am J Emerg Med 31(4):759.e1–2. https://doi.org/10.1016/j.ajem.2012.11.022CrossRef

30.

Shaver KJ, Adams C, Weiss SJ (2006) Acute myocardial infarction after administration of low-dose intravenous epinephrine for anaphylaxis. CJEM 8(4):289–294. https://doi.org/10.1017/s1481803500013890CrossRefPubMed

31.

Shrestha B, Kafle P, Thapa S, Dahal S, Gayam V, Dufresne A (2018) Intramuscular epinephrine-induced transient ST-elevation myocardial infarction. J Investig Med High Impact Case Rep 6:2324709618785651. https://doi.org/10.1177/2324709618785651CrossRefPubMedPubMedCentral

32.

Tummala K, Maniyal VK, Chandrashekaran R et al (2013) Cardiac anaphylaxis: a case of acute ST-segment elevation myocardial infarction after IM epinephrine for anaphylactic shock. Am J Emerg Med 31(7):1157.e1–3. https://doi.org/10.1016/j.ajem.2013.03.025CrossRef

33.

Park JS, Min JH, Kang JH, In YN (2015) Acute myocardial infarction due to stent thrombosis after administration of intravenous epinephrine for anaphylaxis. Chin Med J (Engl) 128(19):2692–2693. https://doi.org/10.4103/0366-6999.166020CrossRef

34.

O-uchi J, Komukai K, Tohyama J et al (2003) Coronary artery spasm discovered in thorough examination of perioperative VT in a 26-year-old Japanese male. Jpn Heart J 44(6):1021–1026CrossRef

35.

Karch SB (1989) Coronary artery spasm induced by intravenous epinephrine overdose. Am J Emerg Med 7(5):485–488. https://doi.org/10.1016/0735-6757(89)90250-7CrossRefPubMed

36.

Ferry DR, Henry RL, Kern MJ (1986) Epinephrine-induced myocardial infarction in a patient with angiographically normal coronary arteries. Am Heart J 111(6):1193–1195. https://doi.org/10.1016/0002-8703(86)90023-2CrossRefPubMed

Titel: The allergic myocardial infarction dilemma: is it the anaphylaxis or the epinephrine?
verfasst von: Pei Zheng Tan
Nicholas W. S. Chew
Sen Hee Tay
Peter Chang
Publikationsdatum: 05.02.2021
Verlag: Springer US
Erschienen in: Journal of Thrombosis and Thrombolysis / Ausgabe 3/2021
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-021-02389-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2021

Wirkung einer tPA-induzierte Fibrinolyse bei COVID-Patienten eingeschränkt?

Stroke and presence of patent foramen ovale in sickle cell disease

SUPPORT‐AF III: supporting use of AC through provider prompting about oral anticoagulation therapy for AF

Short-term non-vitamin K antagonist oral anticoagulants vs. warfarin in preventing device-related thrombosis after left atrial appendage closure

Can a modified-simplified pulmonary embolism severity index (m-sPESI) be used to predict the need for intensive care in hospitalized COVID-19 patients?